Reduced pteridine derivatives induce apoptosis in PC12 cells

Area of Science:

• Neuroscience
• Biochemistry
• Cell Biology

Background:

• Elevated pteridine levels, including neopterin and 7,8-dihydroneopterin, are observed in cerebrospinal fluid during cerebral infections.
• Pteridines are biologically active compounds with diverse roles in cellular processes.

Purpose of the Study:

• To investigate the potential of various pteridine compounds to induce apoptosis in rat pheochromocytoma (PC12) cells.
• To explore the mechanisms underlying pteridine-induced apoptosis and its implications for neurodegeneration.

Main Methods:

• PC12 cells were exposed to different pteridine compounds (aromatic and reduced forms).
• Apoptosis was assessed, and cell sensitivity was evaluated after terminal differentiation.
• The role of reactive oxygen intermediates was investigated using antioxidants.
• Signaling pathway activation (MAP kinase, JUN/SAP kinase) was analyzed upon exposure to 7,8-dihydroneopterin.

Main Results:

• Reduced pteridines (7,8-dihydroneopterin, 5,6,7,8-tetrahydrobiopterin, 7,8-dihydrobiopterin) significantly increased apoptosis.
• Terminally differentiated cells showed reduced sensitivity to pteridines.
• 7,8-dihydroneopterin and 7,8-dihydrofolic acid notably augmented apoptosis.
• Antioxidants offered partial protection, implicating reactive oxygen intermediates.
• 7,8-dihydroneopterin activated MAP kinase and JUN/SAP kinase signaling pathways.

Conclusions:

• Reduced pteridines can induce apoptosis in neural cells, potentially contributing to neurodegenerative processes.
• Reactive oxygen species and specific kinase pathways are involved in pteridine-induced neurotoxicity.
• Understanding these mechanisms may offer insights into the pathogenesis of neurodegenerative diseases.